WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018102547) TAG-72-BINDING CHIMERIC ANTIGEN RECEPTORS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/102547 International Application No.: PCT/US2017/063950
Publication Date: 07.06.2018 International Filing Date: 30.11.2017
IPC:
A61K 35/17 (2015.01) ,A61K 38/16 (2006.01) ,A61K 39/395 (2006.01) ,C07K 14/705 (2006.01) ,C07K 16/30 (2006.01) ,C07K 16/46 (2006.01) ,C07K 19/00 (2006.01) ,C12N 5/0783 (2010.01)
Applicants: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.[US/US]; 12902 Magnolia Drive Tampa, Florida 33612-9497, US
Inventors: SOLIMAN, Hatem; US
DAVILA, Marco; US
Agent: GILES, Brian; Thomas Horstemeyer LLP 3200 Windy Hill Road SE Suite 1600E Atlanta, Georgia 30339, US
Priority Data:
62/429,24202.12.2016US
62/449,89624.01.2017US
Title (EN) TAG-72-BINDING CHIMERIC ANTIGEN RECEPTORS
(FR) RÉCEPTEURS ANTIGÉNIQUES CHIMÉRIQUES SE LIANT À LA TAG-72
Abstract: front page image
(EN) Disclosed herein are chimeric antigen receptor (CAR) polypeptides that can be used with adoptive cell transfer to target and kill TAG-72-expressing cancers. Also disclosed are immune effector cells, such as T cells or Natural Killer (NK) cells, that are engineered to express these CARs. Therefore, also disclosed are methods of providing an anti-tumor immunity in a subject with a TAG-72-expressing cancer that involves adoptive transfer of the disclosed immune effector cells engineered to express the disclosed CARs.
(FR) L'invention concerne des polypeptides de récepteurs antigéniques chimériques (CAR) qui peuvent être utilisés avec un transfert adoptif de cellules pour cibler et éliminer des cancers exprimant la TAG-72. L'invention concerne également des cellules effectrices immunitaires, telles que des lymphocytes T ou des cellules tueuses naturelles (NK), qui sont modifiées pour exprimer ces CAR. Par conséquent, l'invention concerne également des méthodes permettant de conférer une immunité anti-tumorale à un sujet atteint d'un cancer exprimant la TAG-72 qui implique le transfert adoptif des cellules effectrices immunitaires décrites modifiées pour exprimer les CAR décrits.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)